Home › Funds › SMITH, MOORE & CO. › ABBV

SMITH, MOORE & CO. position in ABBV

ABBVIE INC · Health Care

SMITH, MOORE & CO. reported holding 27,474 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$7.2M, representing 0.47% of its reported portfolio and ranking #49 among its reported holdings. SMITH, MOORE & CO. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)27.47K sh
Reported value held$7.19M
Portfolio Weight0.47%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SMITH, MOORE & CO.'s ABBV position evolved

SMITH, MOORE & CO. first disclosed a stake in ABBV in Q3 2023 at 35,876 shares (US$5.3M). The position peaked in Q3 2026 at 27,474 shares, worth US$7.2M. Across 13 filings, SMITH, MOORE & CO. increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 27,474 shares valued at US$7.2M — a reduction of -1,069 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.88K $5.35M New
Q4 2023 35.12K $5.44M Reduce
Q1 2024 33.38K $6.08M Reduce
Q2 2024 32.00K $5.49M Reduce
Q3 2024 30.16K $5.96M Reduce
Q4 2024 30.25K $5.38M Hold
Q1 2025 29.62K $6.21M Reduce
Q2 2025 28.67K $5.32M Reduce
Q3 2025 29.10K $6.74M Add
Q4 2025 27.60K $6.31M Reduce
Q1 2026 29.26K $6.36M Add
Q2 2026 28.54K $7.18M Reduce
Q3 2026 27.47K $7.19M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has SMITH, MOORE & CO. held ABBV?

SMITH, MOORE & CO. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SMITH, MOORE & CO.'s current position in ABBV?

As of Q3 2026, SMITH, MOORE & CO. holds 27.47K shares of ABBV (ABBVIE INC), valued at $7.19M, representing 0.47% of its reported portfolio and ranking #49.

Has SMITH, MOORE & CO. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), SMITH, MOORE & CO. reduced its position in ABBV. The position peaked in Q3 2026 at 27.47K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.